Control of Fibroblast Growth Factor Receptor Kinase Signal Transduction by Heterodimerization of Combinatorial Splice Variants

REFERENCES

• Amaya, E., T. J. Musci, and M. W. Kirschner. 1991. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell 66:257–270.
   PubMed Web of Science ®Google Scholar
• Anderson, D., C. A. Koch, L. Grey, C. Ellis, M. Moran, and T. Pawson. 1990. Binding of SH2 domains of phospholipase C-7, GAP and Src to activated growth factor receptors. Science 250:979–982.
   PubMed Web of Science ®Google Scholar
• Barinaga, M. 1991. Dimers direct development. Science 251:1176–1177.
   PubMedGoogle Scholar
• Bellot, F., G. Crumley, J. M. Kaplow, J. Schlessinger, M. Jaye, and C. A. Dionne. 1991. Ligand-induced transphosphorylation between different FGF receptors. EMBO J. 10:2849–2854.
   PubMed Web of Science ®Google Scholar
• Cantley, L. C, K. R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, and S. Soltoff. 1991. Oncogenes and signal transduction. Cell 64:281–302.
   PubMed Web of Science ®Google Scholar
• Champion-Arnaud, P., C. Rosin, E. Gilbert, M. C. Gesnel, E. Houssaint, and R. Breathnach. 1991. Multiple mRNAs for pro-teins related to the BEK fibroblast growth factor receptor. Oncogene 9:979–987.
   Google Scholar
• Damm, K., C. C. Thompson, and M. R. Evans. 1989. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature (London) 339:593–597.
   PubMed Web of Science ®Google Scholar
• DeMarzo, A. M., C. A. Beck, S. A. Onate, and D. P. Edwards. 1991. Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-Kda heat shock protein. Proc. Natl. Acad. Sci. USA 88:72–76.
   PubMed Web of Science ®Google Scholar
• Ellis, L., E. Clauser, D. O. Morgan, M. Edery, R. A. Roth, and W. J. Rutter. 1986. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45:721–732.
   PubMed Web of Science ®Google Scholar
• Escobedo, J. A., S. Navankasattusas, W. M. Kavanaugh, D. Milfay, V. A. Fried, and L. T. Williams. 1991. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor. Cell 65:75–82.
   PubMed Web of Science ®Google Scholar
• Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Nature (London) 240:889–895.
   Google Scholar
• Frattali, A. L., J. L. Treadway, and J. E. Pessin. 1992. Trans-membrane signaling by the human insulin receptor kinase: relationship between intramolecular β subunit trans- and cis-autophosphorylation and substrate kinase activation. J. Biol. Chem. 267:19521–19528.
   PubMedGoogle Scholar
• Gu, M., J. O. York, I. Warshawsky, and P. W. Majerus. 1991. Identification, cloning and expression of a cytosolic megakaryo-cyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1. Proc. Natl. Acad. Sci. USA 88:5867–5871.
   PubMedGoogle Scholar
• Harlow, E., and D. Lane. 1988. Antibodies: a laboratory man-ual, p. 313-315. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Heldin, C.-H., A. Ernlund, C. Rorsman, and L. Ronnstrand. 1989. Dimerization of the B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. J. Biol. Chem. 264:8905–8912.
   PubMed Web of Science ®Google Scholar
• Honegger, A. M., R. M. Kris, A. Ullrich, and J. Schlessinger. 1989. Evidence that autophosphorylation of solubilized recep-tors for epidermal growth factor is mediated by intermolecular cross-phosphorylation. Proc. Natl. Acad. Sci. USA 86:925–929.
   PubMed Web of Science ®Google Scholar
• Hou, J., M. Kan, K. McKeehan, G. McBride, P. Adams, and W. L. McKeehan. 1991. Fibroblast growth factor receptors from liver vary in three structural domains. Science 251:665–668.
   PubMedGoogle Scholar
• Hou, J., K. McKeehan, M. Kan, S. A. Carr, M. J. Huddeston, J. W. Crabb, and W. L. McKeehan. 1993. Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin-binding fibroblast growth factor receptor tyrosine kinase (flg). Protein Sci. 2:86–92.
   PubMedGoogle Scholar
• Jaye, M., J. Schlessinger, and C. A. Dionne. 1992. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta 1135:185–199.
   PubMed Web of Science ®Google Scholar
• Johnson, D. E., P. L. Lee, J. Lu, and L. T. Williams. 1990. Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell. Biol. 10:4728–4736.
   PubMed Web of Science ®Google Scholar
• Johnson, D. E., J. Lu, H. Chen, S. Werner, and L. T. Williams. 1991. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglob-ulin domain. Mol. Cell. Biol. 11:4627–4634.
   PubMed Web of Science ®Google Scholar
• Jones, N. 1990. Transcriptional regulation by dimerization: two sides to an incestuous relationship. Cell 61:9–11.
   PubMedGoogle Scholar
• Kan, M., D. Disorbo, J. Hou, H. Hoshi, P. E. Mansson, and W. L. McKeehan. 1988. High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. J. Biol. Chem. 263:11306–11313.
   PubMed Web of Science ®Google Scholar
• Kan, M., J. Huang, P. E. Mansson, H. Yasumitsu, B. Carr, and W. L. McKeehan. 1989. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc. Natl. Acad. Sci. USA 86:7432–7436.
   PubMedGoogle Scholar
• Kan, M., E. Shi, and W. L. McKeehan. 1991. Identification and assay of fibroblast growth factor receptors. Methods Enzymol. 198:158–171.
   PubMedGoogle Scholar
• Kan, M., F. Wang, J. Xu, E. Shi, J. W. Crabb, G. Yan, J. Hou, and W. L. McKeehan. 1993. An essential heparin-binding do-main in the fibroblast growth factor receptor kinase. Science 259:1918–2001.
   PubMed Web of Science ®Google Scholar
• Kan, M., G. Yan, J. Xu, M. Nakahara, and J. Hou. 1992. Receptor phenotype underlies differential response of hepato-cytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF). In Vitro Cell. Dev. Biol. 28A:515–520.
   PubMedGoogle Scholar
• Kashles, O., Y. Yarden, R. Fischer, A. Ullrich, and J. Schless-inger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by het-erodimerization. Mol. Cell. Biol. 11:1454–1463.
   PubMed Web of Science ®Google Scholar
• Koch, C. A., D. Anderson, M. F. Moran, C. Ellis, and T. Pawson. 1991. SH2 and SH3 domains: elements that control interaction of cytoplasmic signaling proteins. Science 252:668–674.
   PubMed Web of Science ®Google Scholar
• Maegawa, H., J. M. Olefsky, S. Thies, D. Boyd, A. Ullrich, and D. A. McClain. 1988. Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation. J. Biol. Chem. 263:12629–12637.
   PubMedGoogle Scholar
• Mansson, P. E., P. Adams, M. Kan, and W. L. McKeehan. 1989. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res. 49:2485–2494.
   PubMed Web of Science ®Google Scholar
• Mohammadi, M., C. A. Dionne, W. Li, T. Spivak, A. M. Honegger, M. Jaye, and J. Schlessinger. 1992. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis with-out affecting mitogenesis. Nature (London) 358:681–684.
   PubMed Web of Science ®Google Scholar
• Mohammadi, M., A. M. Honegger, D. Rotin, R. Fischer, F. Bellot, W. Li, C. A. Dionne, M. Jaye, M. Rubinstein, and J. Schlessinger. 1991. A tyrosine-phosphorylated carboxyl-termi-nal peptide of the fibroblast growth factor receptor (flg) is a binding site for the SH2 domain of phospholipase C-γ1. Mol. Cell. Biol. 11:5068–5078.
   PubMed Web of Science ®Google Scholar
• Partanen, J., T. P. Makela, E. Eerola, J. Korhonen, H. Hirvonen, L. Claesson-Welsh, and K. Alitalo. 1991. FGF-R4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10:1347–1354.
   PubMed Web of Science ®Google Scholar
• Peters, K. G., J. Marie, E. Wilson, H. E. Ives, J. Escobedo, M. Del Rosario, D. Mirda, and L. T. Williams. 1992. Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis. Nature (London) 358:678–681.
   PubMed Web of Science ®Google Scholar
• Rhee, S. G. 1991. Inositol phopholipid-specific phospholipase C: interaction of the γ1 isoform with tyrosine kinase. Trends Biochem. Sci. 16:297–301.
   PubMed Web of Science ®Google Scholar
• Rhee, S. G., P. G. Suh, S. H. Ryu, and S. Y. Lee. 1989. Studies of inositol phospholipid-specific phospholipase C. Science 244:546–550.
   PubMed Web of Science ®Google Scholar
• Schneider, C., R. A. Newman, D. R. Sutherland, U. Asser, and M. F. Greares. 1982. A one-step purification of membrane proteins using a high efficiency immunomatrix. J. Biol. Chem. 257:10766–10769.
   PubMed Web of Science ®Google Scholar
• Shoelson, S. E., M. Boni-Schnetzler, P. F. Pilch, and C. R. Kahn. 1991. Autophosphorylation within insulin receptor β-subunits can occur as an intramolecular process. Biochemistry 30:7740–7746.
   PubMedGoogle Scholar
• Stone, K. L., D. E. McNulty, M. L. LoPresti, J. M. Crawford, R. DeAngelis, and K. R. Williams. 1992. Elution and internal amino acid sequencing of PVDF-blotted proteins, p. 23-25. In R. H. Angeletti (ed.), Techniques in protein chemistry III. Academic Press, Inc., New York.
   Google Scholar
• Summers, M. D., and G. E. Smith. 1988. A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experiment Station Bulletin 1555. Texas Agricultural Experiment Station, College Station.
   Google Scholar
• Tan, J. C, K. Nocka, P. Ray, P. Traktman, and P. Besmer. 1990. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209–212.
   PubMedGoogle Scholar
• Treadway, J. L., B. D. Morrison, D. A. Soos, K. Siddle, J. Olefsky, A. Ullrich, D. A. McClain, and J. E. Pessin. 1991. Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor 1 hybrid receptors. Proc. Natl. Acad. Sci. USA 88:214–218.
   PubMed Web of Science ®Google Scholar
• Ueno, H., H. Colbert, J. A. Escobedo, and L. T. Williams. 1991. Inhibition of PDGFβ receptor signal transduction by co-expression of a truncated receptor. Science 252:844–848.
   PubMedGoogle Scholar
• Ueno, H., M. Gunn, K. Dell, A. Tseng, and L. T. Williams. 1992. A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J. Biol. Chem. 267:1470–1476.
   PubMed Web of Science ®Google Scholar
• Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–212.
   PubMed Web of Science ®Google Scholar
• Xu, J., M. Nakahara, J. W. Crabb, E. Shi, Y. Matuo, M. Fraser, M. Kan, J. Hou, and W. L. McKeehan. 1992. Expression and immunochemical analysis of rat and human recombinant fibroblast growth factor receptor (flg) isoforms. J. Biol. Chem. 267:17792–17803.
   PubMed Web of Science ®Google Scholar
• Yan, G., Y. Fukabori, G. McBride, S. Nikolaropolous, and W. L. McKeehan. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol., in press.
   Google Scholar
• Yan, G., and W. L. McKeehan. Unpublished data.
   Google Scholar
• Yan, G., F. Wang, Y. Fukabori, D. Sussman, J. Hou, and W. L. McKeehan. 1992. Expression and transforming activity of a variant of the heparin-binding fibroblast growth factor receptor (flg) gene resulting from splicing of the alpha exon at an alternated 3'-acceptor site. Biochem. Biophys. Res. Commun. 183:423–430.
   PubMedGoogle Scholar
• Yarden, Y., and J. Schlessinger. 1987. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26:1434–1442.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and J. Schlessinger. 1987. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26:1443–1451.
   PubMed Web of Science ®Google Scholar